Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DXCM compared with PODD: revenue, margins and what each company keeps, and the suppliers and customers both name
DXCM
DexCom Inc
Change
Mkt cap
Revenue
Revenue
PODD
Insulet Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
DXCM
DexCom Inc
vs
PODD
Insulet Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
DXCM
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±6.7%
▲
+2.95%
×0.45
Q2 FY26
±6.2%
▲
+11.95%
×1.92
Q1 FY26
±8.9%
▲
+3.02%
×0.34
Feb 13 '26
±9.3%
▲
+7.59%
×0.82
PODD
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±10.9%
▼
−20.12%
×1.84
Q1 FY26
±9.3%
▼
−9.70%
×1.04
= implied
DXCM realized, solid
PODD realized, hatched
One scale, both sides: full bar = 21%
× = |realized| ÷ implied
Source: market data
Feb 18 '26
±7.6%
▲
+4.76%
×0.63
Q3 FY25
±10.1%
▲
+2.85%
×0.29
DXCM
DexCom Inc
Change
82.33
· pre 82.46
Mkt cap
$30.7B
Revenue
$1.3B
Q3 FY26
Revenue
$4.7B
FY25
PODD
Insulet Corp
Change
149.64
· pre 150.67
· delayed
Pre-market
Sep 2 '83
Mkt cap
$10.4B
Revenue
$802M
Q2 FY26
Revenue
$2.7B
FY25
vs
Compare
Pre-market
Sep 2 '83
DXCM
DexCom Inc
vs
PODD
Insulet Corp
82.33
pre 82.46
Price
149.64
pre 150.67
delayed
$30.7B
Mkt cap
$10.4B
Q3 FY26
$1.3B
Revenue
$802M
Q2 FY26
FY25
$4.7B
Revenue
$2.7B
FY25
Change
Change
DXCM
82.33
vs
PODD
149.64
Pre-market
Sep 2 '83